Reply to managing patients with ulcerative colitis with infliximab in primary and referral gastroenterology centers.
IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
Alessandro
A
Armuzzi
Daniela
D
Pugliese
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D013256:Steroids / Q000008:administration & dosage*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D013256:Steroids; D001379:Azathioprine